Table 4. ReDO drugs included in late-phase clinical trials.
Item | |
---|---|
Number of relevant late-stage trials | 190 |
Number of unique drugs | 72 |
Number of drugs with 5 or more trials | 11 |
Number of drugs with 10 or more trials | 6 |
Item | |
---|---|
Number of relevant late-stage trials | 190 |
Number of unique drugs | 72 |
Number of drugs with 5 or more trials | 11 |
Number of drugs with 10 or more trials | 6 |